Erythroderma

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2365 times

[level-membership-for-dermatology-category]8

Erythroderma

Introduction

• Defined as generalized redness and scaling involving more than 90% of the body surface area (BSA); occasionally applied to patients with slightly less BSA involvement, e.g. when diagnosed earlier in the course of their disease.

• A clinical presentation for a variety of diseases, often divided into three major categories: (1) primary skin disorders; (2) drug-related (Table 8.1); and (3) malignancies, particularly Sézary syndrome and erythrodermic mycosis fungoides.

• In adults (Table 8.2), the most common primary skin disorders are psoriasis (Fig. 8.1) and atopic dermatitis, with allergic contact dermatitis or pityriasis rubra pilaris (Fig. 8.2) less common.

• In addition to atopic dermatitis, causes in infants and neonates (Table 8.3) include inherited ichthyoses, immunodeficiencies, staphylococcal scalded skin syndrome (SSSS), and seborrheic dermatitis.

• Despite varied etiologies, patients have a number of clinical features in common: generalized erythema and desquamation (scaling) (Fig. 8.5), pruritus with secondary changes (e.g., lichenification), dyspigmentation, eruptive seborrheic keratoses (Fig. 8.6), secondary cutaneous infections, ectropion and purulent conjunctivitis; additional findings include palmoplantar keratoderma, nail dystrophy (Fig. 8.7), and alopecia.

• In addition to these shared features, more specific clinical findings and initial sites of involvement may suggest the underlying etiology (see Table 8.2).

• Potential systemic complications: generalized lymphadenopathy, edema, tachycardia, high-output cardiac failure, hepatomegaly, thermoregulatory disturbances, compensatory hypermetabolism, cachexia, hypoalbuminemia, and anemia.

• Dx is often challenging because both clinical and histologic features may be nonspecific; repeat clinical examinations, laboratory evaluations, and skin biopsies are often necessary (Fig. 8.8).

• Despite a thorough evaluation, the cause can remain unknown (idiopathic) in up to a third of patients (see Fig. 8.3).

• Some patients with idiopathic erythroderma eventually develop a cutaneous T-cell lymphoma (CTCL).

• Treatment strategies should address the dermatological symptoms, the underlying etiology, and the associated systemic complications (Table 8.4).

• May represent a serious medical threat to the patient and require hospitalization.

For further information see Ch. 120. From Dermatology, Third Edition.

[/level-membership-for-dermatology-category][not-level-membership-for-dermatology-category]8

Erythroderma